Antivirals: Targeting HBV and Beyond

Investors

Antivirals: Targeting HBV and Beyond

Sep 25, 2018 12:00 PM EDT

James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “Using siRNA to target the HBV transcriptome”